Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
13
References
13
Citations
NaN
KQI